H.R. 2276 · 112th Congress
To require the Director of the United States Patent and Trademark Office to conduct a study on effective ways to provide confirming genetic diagnostic test activity where gene patents and exclusive licensing exist, and for other purposes.
- Stage
- In committee
- Sponsor
- Debbie Wasserman Schultz
- Introduced
- 2011-06-22
- Latest action
- 2011-08-25 · Referred to the Subcommittee on Intellectual Property, Competition and the Internet.
Votes
No linked votes are available for this bill.